创新的肉瘤疗法使用多方面的纳米-PROTAC诱导的EZH2降解和免疫增强增强免疫力
Zhihao Chen1, Yi Tai2, Chuangzhong Deng1
1Department of Musculoskeletal Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, PR China.
研究人员开发了YM@VBM,一种新的纳米PROTAC,以向肉瘤中的EZH2. 这种创新疗法降解了EZH2,激活了抗瘤免疫力,并提供了一种有前途的新型肉瘤治疗方法.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 瘤是具有侵略性的瘤,由于异质性和耐治疗性,治疗选择有限.
- 增强质同类素2 (EZH2) 在瘤中高度表达,但直接向仍然具有挑战性.
- EZH2通过非正规的YAP1.1转录调节在肉瘤进展中发挥关键作用.
研究的目的:
- 研究在肉瘤中EZH2的非正规转录机制.
- 开发一种针对EZH2降解和增强肉瘤抗瘤免疫力的新型治疗策略.
主要方法:
- 开发YM@VBM,一个纳米-PROTAC集成一个多-氧化物系统与一个EZH2降解剂 (YM281 PROTAC).
- 将YM@VBM封装在甲基聚乙烯糖醇-NH2中,以提高生物相容性,并将其纳入微针贴片中,以提供有针对性的输送.
- 评估YM@VBM的功能,包括产生活性氧物种,减少谷氨,光热效应,EZH2降解和抗瘤免疫反应激活.
主要成果:
- 通过强大的EZH2降解,YM@VBM证明了增强的准效率.
- 纳米-PROTAC表现出多模式的抗肉瘤活动,包括过氧化酶类活动和光热效应.
- YM@VBM有效地激活了通过调节髓状细胞衍生的抑制细胞,树突细胞和三级淋巴体结构来激活抗瘤免疫力.
结论:
- 这项研究揭示了EZH2在调节YAP1和驱动肉瘤进展方面的非正规转录作用.
- YM@VBM是一种多功能纳米PROTAC,通过向EZH2并刺激抗瘤免疫力,为肉瘤治疗提供了多方面的方法.
- 工程YM@VBM提出了一种有前途的治疗策略,用于对抗具有挑战性的肉瘤恶性瘤.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
